Focal small bowel perforation: An adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants

被引：31

作者：

Gordon P.V. ^{[1
]}

Young M.L. ^{[2
]}

Marshall D.D. ^{[1
]}

机构：

[1] Department of Pediatrics, University of North Carolina, Chapel Hill, NC

[2] Department of Biostatistics, University of North Carolina, Chapel Hill, NC

来源：

Journal of Perinatology | 2001年 / 21卷 / 3期

关键词：

D O I：

10.1038/sj.jp.7200520

中图分类号：

学科分类号：

摘要：

Objective: We tested the hypothesis that early postnatal dexamethasone (EPD) increases the risk of focal small bowel perforation (FSBP) in extremely low birth weight (ELBW) infants. Study Design: The techniques of meta-analysis were applied to studies evaluating EPD, which we identified through a systematic literature search. Studies were included if they were randomized, placebo-controlled trials of EPD, enrolled infants with birth weights ≤1000 g, and reported FSBP as an outcome variable. The Breslow-Day test was used to assess for homogeneity and a summary odds ratio was calculated using the Mantel-Haenszel exact method. Results: Four studies, with a pooled sample of 1383 infants, were included in the primary analysis. The Breslow-Day test showed a p-value of 0.61, indicating homogeneity among the studies. FSBP was significantly higher in EPD treated infants [odds ratio 1.91, 95% confidence interval (CI) 1.21, 3.07; p = 0.004]. Conclusion: EPD increases the risk of FSBP in ELBW infants.

引用

页码：156 / 160

页数：4

共 27 条

[1]

Bucheit J.Q., Stewert D.L., Clinical comparison of localized intestinal perforation and necrotizing enterocolitis in neonates, Pediatrics, 93, pp. 32-36, (1994)

[2]

Novack C.M., Waffrin F., Sills J.H., Pousti T.J., Warden J.M., Cunningham M.D., Focal intestinal perforation in the extremely-low-birth-weight infant, J Perinatol, 14, pp. 450-453, (1994)

[3]

Raghuveer G., Speidel B., Marlow N., Porter H., Focal intestinal perforation in preterm infants is an emerging disease, Acta Paediatr, 85, pp. 237-239, (1996)

[4]

Kuhl G., Wille L., Bolkonius M., Seyberth H.W., Intestinal perforation associated with indomethacin treatment in premature infants, Eur J Pediatr, 143, (1985)

[5]

McDonnell M., Evans N., Upper and lower gastrointestinal complications with dexamethasone despite H2 antagonists, J Paediatr Child Health, 31, pp. 152-154, (1995)

[6]

Ng P.C., Fok T.F., So K.W., Wong W., Yip P.K.F., Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for broncho-pulmonary dysplasia, Pediatr Surg Int, 12, pp. 211-212, (1997)

[7]

Alpan G., Eyal F., Vinograd I., Udassin R., Amir G., Mogle P., Glick B., Localized intestinal perforation after enteral administration of indomethacin in premature infants, J Pediatr, 106, (1985)

[8]

Loyd J.R., The etiology of gastrointestinal perforations in the newborn, J Pediatr Surg, 4, (1969)

[9]

McCarthy D.W., Qualman S., Besner G.E., Absent intestinal musculature: Anatomic evidence of an embryonic origin of the lesion, J Pediatr Surg, 29, pp. 1476-1478, (1994)

[10]

Liwin A., Avidor I., Schujman E., Grunebaum M., Wilunsky E., Wollock Y., Reisner S.H., Neonatal intestinal perforation caused by congenital defects of the intestinal musculature, Am J clin Pathol, 81, pp. 77-80, (1984)

← 1 2 3 →